Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Pharmaceutical Research|September 9, 2010
Multifunctional peptide-PEG intercalating conjugates: programmatic of gene delivery to the blood-brain barrierHongwei Zhang, Trevor Gerson, Michelle L Varney, et al.Molecular Cancer Therapeutics|March 8, 2013
Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasisBhawna Sharma, Dhananjay M Nawandar, Kalyan C Nannuru, et al.The American Journal of Pathology|October 27, 2019
IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil RecruitmentLingyun Wu, Mohammad Awaji, Sugandha Saxena, et al.Cancer Letters|November 2, 2010
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesMichelle L Varney, Seema Singh, Aihua Li, et al.Omics : a Journal of Integrative Biology|April 7, 2007
Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysisAnguraj Sadanandam, Michelle L Varney, Leo Kinarsky, et al.Angiogenesis|September 1, 2005
Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesisAihua Li, Michelle L Varney, Jason Valasek, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Isoform-Specific Functions of p73 Drive Survival and Chemoresistance in Diffuse Large B-Cell LymphomaHesham M Hassan, Michelle L Varney, Dennis D Weisenburger, et al.Bioorganic & Medicinal Chemistry|March 18, 2017
Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthaseVeronica S Wills, Joseph I Metzger, Cheryl Allen, et al.Cancer Research|April 22, 2010
Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interfaceKalyan C Nannuru, Mitsuru Futakuchi, Michelle L Varney, et al.Experimental Hematology & Oncology|February 10, 2022
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myelomaStaci L Haney, Michelle L Varney, Jacob T Williams, et al.Pageof 6